Trial Outcomes & Findings for Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer (NCT NCT02111681)

NCT ID: NCT02111681

Last Updated: 2025-09-26

Results Overview

Feasibility is defined as completion of all treatments using the DIBH treatment plan and Calypso transponders.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

48 participants

Primary outcome timeframe

2 years

Results posted on

2025-09-26

Participant Flow

Participant milestones

Participant milestones
Measure
Calypso-based Deep Inspiration Breath Hold (DIBH)
This trial will investigate the feasibility of implanted anchored Beacon ® electromagnetic lung transponders (Calypso ®) to guide and monitor deep-inspiration breathhold (DIBH) treatments in patients with inoperable thoracic malignancies. Bronchoscopic Calypso Beacon Implantation, Simulation - Free-breathing scan - 4D CT scan,- DIBH CT scan Radiation - Treatment setup, - Calypso signal recording, - RT treatment with DIBH with or without visual biofeedback Follow-up - 3 and 6 months after RT with diagnostic CT chest Calypso Beacon Implantation: Bronchoscopic Calypso Beacon Implantation
Overall Study
STARTED
48
Overall Study
COMPLETED
37
Overall Study
NOT COMPLETED
11

Reasons for withdrawal

Reasons for withdrawal
Measure
Calypso-based Deep Inspiration Breath Hold (DIBH)
This trial will investigate the feasibility of implanted anchored Beacon ® electromagnetic lung transponders (Calypso ®) to guide and monitor deep-inspiration breathhold (DIBH) treatments in patients with inoperable thoracic malignancies. Bronchoscopic Calypso Beacon Implantation, Simulation - Free-breathing scan - 4D CT scan,- DIBH CT scan Radiation - Treatment setup, - Calypso signal recording, - RT treatment with DIBH with or without visual biofeedback Follow-up - 3 and 6 months after RT with diagnostic CT chest Calypso Beacon Implantation: Bronchoscopic Calypso Beacon Implantation
Overall Study
Death
5
Overall Study
Lack of Efficacy
2
Overall Study
Progression of disease
4

Baseline Characteristics

Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Calypso-based Deep Inspiration Breath Hold (DIBH)
n=48 Participants
This trial will investigate the feasibility of implanted anchored Beacon ® electromagnetic lung transponders (Calypso ®) to guide and monitor deep-inspiration breathhold (DIBH) treatments in patients with inoperable thoracic malignancies. Bronchoscopic Calypso Beacon Implantation, Simulation - Free-breathing scan - 4D CT scan,- DIBH CT scan Radiation - Treatment setup, - Calypso signal recording, - RT treatment with DIBH with or without visual biofeedback Follow-up - 3 and 6 months after RT with diagnostic CT chest Calypso Beacon Implantation: Bronchoscopic Calypso Beacon Implantation
Age, Continuous
69 years
n=99 Participants
Sex: Female, Male
Female
27 Participants
n=99 Participants
Sex: Female, Male
Male
21 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
41 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
2 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
6 Participants
n=99 Participants
Race (NIH/OMB)
White
40 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Region of Enrollment
United States
48 Participants
n=99 Participants

PRIMARY outcome

Timeframe: 2 years

Feasibility is defined as completion of all treatments using the DIBH treatment plan and Calypso transponders.

Outcome measures

Outcome measures
Measure
Calypso-based Deep Inspiration Breath Hold (DIBH)
n=48 Participants
This trial will investigate the feasibility of implanted anchored Beacon ® electromagnetic lung transponders (Calypso ®) to guide and monitor deep-inspiration breathhold (DIBH) treatments in patients with inoperable thoracic malignancies. Bronchoscopic Calypso Beacon Implantation, Simulation - Free-breathing scan - 4D CT scan,- DIBH CT scan Radiation - Treatment setup, - Calypso signal recording, - RT treatment with DIBH with or without visual biofeedback Follow-up - 3 and 6 months after RT with diagnostic CT chest Calypso Beacon Implantation: Bronchoscopic Calypso Beacon Implantation
Feasibility of Calypso Transponders
Participants who completed all treatments using DIBH treatment plan and Calypso transponders
46 Participants
Feasibility of Calypso Transponders
Participants who did not complete all treatments using DIBH treatment plan and Calypso transponders
2 Participants

SECONDARY outcome

Timeframe: 2 years

Population: Data not collected due to the study team being unable to secure appropriate visual feedback devices to assess this objective.

We will compare the visual vs no visual biofeedback treatments (done for each patient) by the number of treatment interruptions.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 2 years

will be measured in all 3 dimensions and the euclidean distance will be calculated in milimeters/mm, which will then be correlated with the normal tissue dosimetry by regression analysis.

Outcome measures

Outcome measures
Measure
Calypso-based Deep Inspiration Breath Hold (DIBH)
n=48 Participants
This trial will investigate the feasibility of implanted anchored Beacon ® electromagnetic lung transponders (Calypso ®) to guide and monitor deep-inspiration breathhold (DIBH) treatments in patients with inoperable thoracic malignancies. Bronchoscopic Calypso Beacon Implantation, Simulation - Free-breathing scan - 4D CT scan,- DIBH CT scan Radiation - Treatment setup, - Calypso signal recording, - RT treatment with DIBH with or without visual biofeedback Follow-up - 3 and 6 months after RT with diagnostic CT chest Calypso Beacon Implantation: Bronchoscopic Calypso Beacon Implantation
Measure the Residual Intrafraction Tumor Motion
3 mm
Interval 2.0 to 5.0

Adverse Events

Calypso-based Deep Inspiration Breath Hold (DIBH)

Serious events: 8 serious events
Other events: 10 other events
Deaths: 30 deaths

Serious adverse events

Serious adverse events
Measure
Calypso-based Deep Inspiration Breath Hold (DIBH)
n=48 participants at risk
This trial will investigate the feasibility of implanted anchored Beacon ® electromagnetic lung transponders (Calypso ®) to guide and monitor deep-inspiration breathhold (DIBH) treatments in patients with inoperable thoracic malignancies. Bronchoscopic Calypso Beacon Implantation, Simulation - Free-breathing scan - 4D CT scan,- DIBH CT scan Radiation - Treatment setup, - Calypso signal recording, - RT treatment with DIBH with or without visual biofeedback Follow-up - 3 and 6 months after RT with diagnostic CT chest Calypso Beacon Implantation: Bronchoscopic Calypso Beacon Implantation
Gastrointestinal disorders
Esophagitis
2.1%
1/48 • 2 years
Respiratory, thoracic and mediastinal disorders
Pneumonitis
2.1%
1/48 • 2 years
Respiratory, thoracic and mediastinal disorders
Cough
4.2%
2/48 • 2 years
Injury, poisoning and procedural complications
IV contrast allergy
2.1%
1/48 • 2 years
Respiratory, thoracic and mediastinal disorders
Hemoptysis
2.1%
1/48 • 2 years
Cardiac disorders
Atrial Flutter
2.1%
1/48 • 2 years
Infections and infestations
Bacteremia
2.1%
1/48 • 2 years
General disorders
Fever
2.1%
1/48 • 2 years
Respiratory, thoracic and mediastinal disorders
Pneumonia
6.2%
3/48 • 2 years

Other adverse events

Other adverse events
Measure
Calypso-based Deep Inspiration Breath Hold (DIBH)
n=48 participants at risk
This trial will investigate the feasibility of implanted anchored Beacon ® electromagnetic lung transponders (Calypso ®) to guide and monitor deep-inspiration breathhold (DIBH) treatments in patients with inoperable thoracic malignancies. Bronchoscopic Calypso Beacon Implantation, Simulation - Free-breathing scan - 4D CT scan,- DIBH CT scan Radiation - Treatment setup, - Calypso signal recording, - RT treatment with DIBH with or without visual biofeedback Follow-up - 3 and 6 months after RT with diagnostic CT chest Calypso Beacon Implantation: Bronchoscopic Calypso Beacon Implantation
Respiratory, thoracic and mediastinal disorders
Cough
12.5%
6/48 • 2 years
Respiratory, thoracic and mediastinal disorders
Hemoptysis
2.1%
1/48 • 2 years
Respiratory, thoracic and mediastinal disorders
Dyspnea
2.1%
1/48 • 2 years
Infections and infestations
Pneumonia
6.2%
3/48 • 2 years
Cardiac disorders
Supraventricular tachycardia/SVT
2.1%
1/48 • 2 years

Additional Information

Dr. Daphna Gelblum, MD

Memorial Sloan Kettering Cancer Center

Phone: 914-367-7273

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place